Clinical Trial Update: Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating prophylaxis and treatment of cytokine release syndrome with siltuximab prior to epcoritamab in non-Hodgkin lymphoma pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Release Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)
• Sylvant (siltuximab)

Snippet

Sponsor: Taylor Brooks | Conditions: Non-Hodgkin Lymphoma, Cytokine Release Syndrome | Phase 1 | Status: RECRUITING